|
OTUD6B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.54540000019132E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.26620000001832E-06 |
| Normal-vs-Stage2 |
5.77029999999645E-05 |
| Normal-vs-Stage3 |
3.46559999997442E-06 |
| Normal-vs-Stage4 |
8.96410000006398E-07 |
| Stage1-vs-Stage2 |
2.874000E-01 |
| Stage1-vs-Stage3 |
2.144600E-01 |
| Stage1-vs-Stage4 |
5.008300E-02 |
| Stage2-vs-Stage3 |
9.170800E-01 |
| Stage2-vs-Stage4 |
5.066400E-01 |
| Stage3-vs-Stage4 |
4.008000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.33029999968859E-07 |
| Normal-vs-AfricanAmerican |
8.979900E-03 |
| Normal-vs-Asian |
5.008900E-04 |
| Caucasian-vs-AfricanAmerican |
6.160800E-01 |
| Caucasian-vs-Asian |
7.982800E-01 |
| AfricanAmerican-vs-Asian |
7.816800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11679999692527E-08 |
| Normal-vs-Female |
2.84859999999387E-06 |
| Male-vs-Female |
4.511800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.93799999999823E-05 |
| Normal-vs-Age(41-60Yrs) |
1.64649999967459E-07 |
| Normal-vs-Age(61-80Yrs) |
9.37619999974437E-07 |
| Normal-vs-Age(81-100Yrs) |
4.200100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.596300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.626100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.929000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.665800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.770400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.115800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.082000E-01 |
| Classical-VS-Follicular |
1.678760E-01 |
| Classical-VS-Other |
4.566600E-01 |
| Classical-VS-Normal |
3.80870000005196E-06 |
| Tall-VS-Follicular |
6.587400E-01 |
| Tall-VS-Other |
6.243600E-01 |
| Tall-VS-Normal |
2.264800E-03 |
| Follicular-VS-Other |
8.107800E-01 |
| Follicular-VS-Normal |
1.86476999999297E-05 |
| Other-VS-Normal |
2.481700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.34459999800995E-08 |
| Normal-vs-N1 |
9.630200E-04 |
| N0-vs-N1 |
2.598600E-01 |
|
|
